Matthew Ebbel, Director at AdaptHealth Corp. (AHCO), bought 43,264 shares at $16.20 ($701K) on 2022-05-16, disclosed to the SEC on 2022-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.20 | 21,632 | $350K | 50.0% |
| 2 | $16.20 | 21,632 | $350K | 50.0% |
| Total | $16.20 avg | 43,264 | $701K | 100% |
| Filing → |
| AHCO | BUY | 2022-03-15 | $652K | — | Filing → |